Navigation Links
Dynatronics Announces Increases in Pre-tax Profits and Net Income for the Quarter Ended December 31, 2009

SALT LAKE CITY, Jan. 13 /PRNewswire-FirstCall/ -- Dynatronics Corporation (Nasdaq: DYNT) expects increases in pre-tax profits and net income for the quarter ended December 31, 2009.  Final results will be announced in the next few weeks.

Higher than expected sales in the month of December combined with reductions in expenses support the company's expectations of pre-tax profits in the range of $275,000 to $300,000 for the quarter ended December 31, 2009 compared to pre-tax profits of $89,917 for the quarter ended December 31, 2008.  Net income is expected to be approximately $170,000 to $185,000 for the quarter ended December 31, 2009 compared to net income of $54,598 for the quarter ended December 31, 2008.

"The second quarter is typically a strong sales and profit quarter for the company, but this exceeded our expectations," said Kelvyn H. Cullimore, chairman and president of Dynatronics. "Given the ongoing challenges to economic growth in the United States this increase in profitability over last year is very gratifying and indicative of improved operating efficiencies along with increased sales of high margin capital equipment."

"Looking ahead, we anticipate continued improvement in sales and net income from the expansion of our direct sales force and the preferred vendor agreements with large chains of clinics which were recently announced," added Cullimore.  "Our velocity continues to increase in a positive direction, and we expect this trend to continue."

Dynatronics manufactures, markets and distributes advanced-technology medical devices, orthopedic soft goods and supplies, treatment tables and rehabilitation equipment for the physical therapy, sports medicine, chiropractic, podiatry, plastic surgery, dermatology and other related medical, cosmetic and aesthetic markets. More information regarding Dynatronics is available at

This press release contains forward-looking statements. Those statements include references to the company's expectations and similar statements such as the statement regarding  increases in pre-tax profits and net income for the quarter ended December 31, 2009 and the expectation for continued improvement in sales and net income from the expansion of the company's direct sales force and the preferred vendor agreements with large chains of clinics.  Actual results may vary from the views expressed in the forward-looking statements contained in this release. The development and sale of the company's products are subject to a number of risks and uncertainties, including, but not limited to, changes in the regulatory environment, competitive factors, inventory risks due to shifts in market demand, market demand for the company's products, availability of financing at cost effective rates, and the risk factors listed from time to time in the company's SEC reports including, but not limited to, the report on Form 10-K for the year ended June 30, 2009.

SOURCE Dynatronics Corporation



SOURCE Dynatronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dynatronics Inks Preferred Vendor Agreement with 1,100 Member Preferred Therapy Providers, Inc.
2. Dynatronics Receives 180-Day NASDAQ Extension
3. Dynatronics Named Sole-Source Supplier to Benchmark Physical Therapy
4. Dynatronics Announces Positive Financial Results for Quarter
5. Dynatronics to Release First Quarter Results Friday, November 13, 2009; Conference Call Set for 1:30 p.m. ET
6. Dynatronics Will Request Hearing With Nasdaq Regarding Listing Status
7. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
8. The Foundry Announces Completion of Series A Financing for Twelfth Company
9. DATATRAK International, Inc. Announces Year-End Backlog
10. Stryker Corporation Announces Pricing of Senior Notes
11. Sarnova Announces Acquisition of CVC, Inc. to Expand Portfolio of Specialty Medical Products
Post Your Comments:
(Date:6/23/2016)... 23, 2016 , , , ... 7, 2016 , , , , LOCATION: , , , ... , , , EXPERT PANELISTS:  , , , Frost & Sullivan,s ... Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program ... global pharmaceutical industry is witnessing an exceptional era. Several new demand ...
(Date:6/23/2016)...  Guerbet announced today that it has been named ... . One of 12 suppliers to receive ... support of Premier members through exceptional local customer service ... to lower costs. ... outstanding customer service from Premier," says Massimo Carrara ...
(Date:6/23/2016)... -- The Biotechnology industry might still be ... opportunities to investors. assesses the recent performances of ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ), and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN ... complimentary trade alerts at: ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can ... CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn ... X . Simply select a ProHand generator and drag it above media or text ...
(Date:6/25/2016)... Canada (PRWEB) , ... June 25, 2016 , ... Conventional ... pursuit of success. In terms of the latter, setting the bar too high can ... risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... ... ... National recruitment firm Slone Partners is pleased to announce the ... as Vice President of North American Capital Sales at HTG Molecular . ... team in the commercialization of the HTG EdgeSeq system and associated reagents in North ...
Breaking Medicine News(10 mins):